share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  08/29 09:15
Moomoo AI 已提取核心訊息
On August 29, 2024, Safety Shot, Inc., a Delaware-based wellness company, announced groundbreaking clinical trial results for its product, Safety Shot, which is designed to reduce blood alcohol content and alleviate symptoms associated with excessive drinking. The double-blind, randomized, placebo-controlled study demonstrated a significant increase in aldehyde dehydrogenase activity and a decrease in acetaldehyde levels, leading to a rapid reduction in blood alcohol content and associated toxins within 30 minutes. The company's COO and Co-Inventor, David Sandler, highlighted the product's unique patented formula and its ability to preemptively address the negative effects of heavy alcohol consumption. Safety Shot, Inc. is expanding its product line, which includes a 12oz drink, 4oz shot, and dry powder stick pack, and is introducing business-to-business sales throughout 2024. The press release also contained forward-looking statements regarding the product's development and commercialization, as well as the company's compliance with laws and potential risks as detailed in its SEC filings.
On August 29, 2024, Safety Shot, Inc., a Delaware-based wellness company, announced groundbreaking clinical trial results for its product, Safety Shot, which is designed to reduce blood alcohol content and alleviate symptoms associated with excessive drinking. The double-blind, randomized, placebo-controlled study demonstrated a significant increase in aldehyde dehydrogenase activity and a decrease in acetaldehyde levels, leading to a rapid reduction in blood alcohol content and associated toxins within 30 minutes. The company's COO and Co-Inventor, David Sandler, highlighted the product's unique patented formula and its ability to preemptively address the negative effects of heavy alcohol consumption. Safety Shot, Inc. is expanding its product line, which includes a 12oz drink, 4oz shot, and dry powder stick pack, and is introducing business-to-business sales throughout 2024. The press release also contained forward-looking statements regarding the product's development and commercialization, as well as the company's compliance with laws and potential risks as detailed in its SEC filings.
2024年8月29日，總部位於特拉華州的健康公司Safety Shot, Inc.宣佈了該公司產品Safety Shot的突破性臨床試驗結果。該產品旨在降低血液中的酒精含量，緩解過量飲酒所帶來的症狀。這項雙盲、隨機、安慰劑對照研究顯示，該產品能顯著增加醛脫氫酶活性，降低乙醛水平，從而在30分鐘內迅速降低血液中的酒精含量和相關毒素。該公司的首席運營官和共同發明者David Sandler強調了該產品獨特的專利配方及其預防性應對大量飲酒所帶來的負面影響的能力。Safety Shot, Inc.正在擴大其產品線，包括12盎司飲料、4盎司Shot以及乾粉棒，同時於2024年全面推出業務對業務銷售。該新聞稿還提及了關於該產品開發和商業化以及該公司遵守法律和潛在風險的前瞻性陳述，詳情在其SEC備案文件中。
2024年8月29日，總部位於特拉華州的健康公司Safety Shot, Inc.宣佈了該公司產品Safety Shot的突破性臨床試驗結果。該產品旨在降低血液中的酒精含量，緩解過量飲酒所帶來的症狀。這項雙盲、隨機、安慰劑對照研究顯示，該產品能顯著增加醛脫氫酶活性，降低乙醛水平，從而在30分鐘內迅速降低血液中的酒精含量和相關毒素。該公司的首席運營官和共同發明者David Sandler強調了該產品獨特的專利配方及其預防性應對大量飲酒所帶來的負面影響的能力。Safety Shot, Inc.正在擴大其產品線，包括12盎司飲料、4盎司Shot以及乾粉棒，同時於2024年全面推出業務對業務銷售。該新聞稿還提及了關於該產品開發和商業化以及該公司遵守法律和潛在風險的前瞻性陳述，詳情在其SEC備案文件中。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息